Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
J Hematol Oncol
; 6: 78, 2013 Oct 12.
Article
in En
| MEDLINE
| ID: mdl-24283803
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Daunorubicin
/
Tumor Suppressor Protein p53
/
Protein Kinase Inhibitors
/
Naphthyridines
Limits:
Humans
Language:
En
Journal:
J Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2013
Type:
Article